PTC Therapeutics pioneers pharmaceutical science to transform lives and treat rare diseases, like Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Huntington's Disease, Leukemia, …

Learn about PTC Therapeutics, a global biopharmaceutical company. We are fueled by science, and committed to transforming the lives of patients with rare diseases.

PTC has been a pioneer in the development of breakthrough rare disease therapies, delivering a number of firsts for patients who previously had no other treatment options. Our strategy …

Jan 13, 2025 · PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Read the latest updates on innovations, research, rare disease treatments, business & finance, and community relations at PTC Therapeutics.

We have focused our research efforts on two scientific platforms—splicing and inflammation and ferroptosis — where PTC has unique expertise to discover and advance to the clinic …

PTC is an established global biopharmaceutical company that delivers transformative therapies for people living with rare diseases. For 25 years, we have been harnessing our scientific …

The executive leadership team at PTC Therapeutics is a profoundly inspiring group of innovators working toward a brighter future for rare disease treatments.

WARREN, N.J. , Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 3, 2025 , the company approved 1,200 restricted stock units ("RSUs"), …

We are deeply committed to patients living with rare diseases who have little-to-no treatment options, and this passion fuels and inspires us. Our commercial and development efforts are …